Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TGTX
#1195
TG Therapeutics, Inc.
30.0
9
-0.36%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.36%
Monthly Change
-2.37%
6 month change
+5.28%
Year Change
+6.33%
Previous Close
30.2
0
Open
30.0
9
Bid
Ask
Low
30.0
9
High
30.0
9
Volume
136
Markets
US Stock Market
Healthcare
TGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
TG Therapeutics presents BRIUMVI data at ACTRIMS forum
TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth
TG Therapeutics to present BRIUMVI data at ACTRIMS forum
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight (NASDAQ: GMAB)
TG Therapeutics stock holds Overweight rating at Cantor Fitzgerald
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results